Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Holy smokes

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jun 08, 2022 4:50pm

162 Views

Post# 34741688

RE:RE:Holy smokes

Nothing to worry about.

- only for early stage rectal cancer
- only for a very specific and rare mutation of this cancer that represents 10% of the rectal cancer
- they don't know if this could apply to other type of cancers

TLT is into late-stage cancers. With no discrimination among genetic profiles of patients, so a much larger pool of patients.

The story of our Ph. 1b patients #5-6, that had tried everything, is much more impressive because this was a late-stage cancer and they only needed 1 single dose of TLD-1433. That's all.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023